text: Elan gets FDA approval for Tysabri MS treatment LONDON (CBS.MW) -- Elan (UK:ELA) (ELN) and partner Biogen (BIIB) said the FDA has approved new drug Tysabri to treat relapsing forms of multiple sclerosis.